Treatment of hemorrhagic gastritis by Ankaferd blood stopper versus Omeprazole: experimental randomized rat models

Batgi, Hikmetullah; Akbal, Erdem; Kocak, Erdem; Akyurek, Omer; KÖKLÜ, SEYFETTİN; Donmez, Melahat; Gunes, Fahri

doi:10.1007/s00508-015-0762-2

Treatment of hemorrhagic gastritis by Ankaferd blood stopper versus Omeprazole: experimental randomized rat models

Copy For Citation

Batgi H., Akbal E., Kocak E., Akyurek O., KÖKLÜ S., Donmez M., ...More

WIENER KLINISCHE WOCHENSCHRIFT, vol.128, 2016 (SCI-Expanded)

Publication Type: Article / Article
Volume: 128
Publication Date: 2016
Doi Number: 10.1007/s00508-015-0762-2
Journal Name: WIENER KLINISCHE WOCHENSCHRIFT
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Hacettepe University Affiliated: Yes

Abstract

Ankaferd blood stopper (ABS) is a herbal extract that enhances mucosal healing. It has therapeutic potential in the management of external hemorrhage and controlling gastrointestinal bleeding associated with various benign lesions refractory to conventional antihemorrhagic measures. The aim of this experimental study was to assess the effects of ABS on hemorrhagic lesions and compare them with omeprazole.